Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01261520 · ClinicalTrials.gov registry record · Phase 3
Chinese Women and Mammography Screening
A Phase 3 study of Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 671
- Enrollment target
- 1
- Study location
NCT01261520: Completed Phase 3 study of Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline, sponsored by Georgetown University.
NCT01261520 is a Phase 3 study of Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline that has completed, run by Georgetown University. The registered enrollment target is 671 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01261520, a Phase 3 study of Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 671 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examined whether a culturally-tailored video has a greater impact on increasing mammography use in Chinese American women and improving barriers to mammography screening compared to a generic, non-tailored video and a printed fact sheet (control group).
Conditions Studied
Interventions
- BEHAVIORAL Culturally-tailored video
Study Locations (1)
District of Columbia
- Cancer Control Program, Georgetown University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 671 participants |
| Start Date | 2005-07 |
| Phase | Phase 3 |
What the finished NCT01261520 record still lists
NCT01261520 is an interventional study that assigns participants to a tested intervention. The registered 671 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (13% lower).
The record links to 1 condition, with Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline appearing as the primary indexed condition, and to 1 intervention - of which Culturally-tailored video is the first listed.
NCT01261520 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01261520 about?
NCT01261520 is a clinical study titled "Chinese Women and Mammography Screening". This study examined whether a culturally-tailored video has a greater impact on increasing mammography use in Chinese American women and improving barriers to mammography screening compared to a generic, non-tailored video and a printed fact sheet (control group).
What is the current status of trial NCT01261520?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 671 participants. The study started on 2005-07.
What conditions does trial NCT01261520 study?
This clinical trial studies the following conditions: Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline.
What interventions are being tested in trial NCT01261520?
The interventions under investigation include: Culturally-tailored video (BEHAVIORAL).
Who is sponsoring clinical trial NCT01261520?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01261520 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01261520's enrollment target sits among peer trials
671 544th of 2000 higher than 1,455 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07185009 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05452031 · 672 participants · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- NCT05493254 · 672 participants · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia